Found: 7
Select item for more details and to access through your institution.
Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
- Published in:
- Molecular Cancer, 2005, v. 4, p. 2, doi. 10.1186/1476-4598-4-2
- By:
- Publication type:
- Article
Activists: some walls are not meant to be breached.
- Published in:
- 2007
- By:
- Publication type:
- Letter
The biological effects of interleukin 6.
- Published in:
- Medicinal Research Reviews, 1996, v. 16, n. 1, p. 87, doi. 10.1002/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.0.CO;2-Q
- By:
- Publication type:
- Article
Six-word rule could turn description into plagiarism.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines.
- Published in:
- BMC Biotechnology, 2010, v. 10, p. 79, doi. 10.1186/1472-6750-10-79
- By:
- Publication type:
- Article
Potential use of STAT3 inhibitors in targeted prostate cancer therapy: future prospects.
- Published in:
- OncoTargets & Therapy, 2012, v. 5, p. 119, doi. 10.2147/OTT.S32559
- By:
- Publication type:
- Article
IL-6 signaling by STAT3 participates in the change from hyperplasia to neoplasia in NRP-152 and NRP-154 rat prostatic epithelial cells.
- Published in:
- 2001
- By:
- Publication type:
- journal article